Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Holland, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holland, E. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Mouse Model for Glioma: Biology, Pathology, and Therapeutic Opportunities

Eric C. Holland

M.D. Anderson Cancer Center, Department of Neurosurgery, Houston, Texas 77030

The epidermal growth factor receptor (EGFR) gene is amplified or mutated in 30-50% of human glioblastoma multiforme. These mutations are usually associated with deletions of the INK4{alpha}-ARF locus, which encodes 2 gene products (p16INK4a and p19ARF) involved in cell cycle arrest and apoptosis. We have investigated the role of EGFR mutation in gliomagenesis using avian retroviral vectors to transfer a mutant EGFR gene to glial precursors and astrocytes in transgenic mice. These mice express tv-a, a gene encoding the retrovirus receptor TVA, which is under the control of brain cell type-specific promoters. We demonstrate that expression of a constitutively active, mutant form of EGFR in cells in the glial lineage can induce lesions with many similarities to human gliomas, including increased cell density, vascular proliferation, and immunohistochemical staining for glial fibrillary acidic protein (GFAP) and nestin. We also demonstrate that primary astrocytes cultured from transgenic mice expressing tv-a from the GFAP promoter are efficiently infected in culture, and such genetically modified cell cultures can be tumorigenic in nude mice. The combinations of genetic lesions (eg, mutated EGFR, INK4a-/-) leading to tumor formation in these 2 mouse systems are similar to those found in human gliomas. These genetically defined animal models for gliomas will allow for the testing of therapies that are targeted specifically at the gene products involved in the pathogenesis of gliomas.

Key Words: Epidermal growth factor receptor (EGRF) gene • INK4a-ARF • gliomagenesis • signal transduction • cell cycle arrest

References

  • Bates P., Young JA, Varmus HE (1993). A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 74: 1043-1051.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Donehower LA, Godley LA, Aldaz CM, Pyle R., Shi YP, Pinkel D., Grey J., Bradley A., Medina D., Varmus HE (1995). Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 9: 882-895.[Abstract/Free Full Text]
  • Donehower LA, Harvey M., Slagle BL, McArthur MJ, Montgomery CA, Butel J., Bradley A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221.[CrossRef][Medline] [Order article via Infotrieve]
  • Ekstrand AJ, Sugawa N., James CD, Collins VP (1992). Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA 89: 4309-4313.[Abstract/Free Full Text]
  • Hayashi Y., Ueki K., Waha A., Wiestler OD, Louis DN, von Deimling A. (1997). Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme. Brain Pathol 7: 871-875.[Web of Science][Medline] [Order article via Infotrieve]
  • He J., Allen JR, Collins VP, Allalunis-Turner MJ, Godbout R., Day RS, James CD (1994). CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma lines. Cancer Res 54: 5804-5807.[Abstract/Free Full Text]
  • He J., Olson JJ, James CD (1995). Lack of pl6INK4 or retinoblastoma protein (pRb) or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 55: 4833-4836.[Abstract/Free Full Text]
  • Holland EC, Hively WP, DePinho RA, Varmus HE (1998). A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev 12: 3675-3685.[Abstract/Free Full Text]
  • Holland EC, Hively WP, Gallo V., Varmus HE (1998). Overexpression of cdk4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes, modeling mutations in the G1 arrest pathway in human gliomas. Genes Dev 12: 3644-3649.[Abstract/Free Full Text]
  • Holland EC, Varmus HE (1998). Basic fibroblast growth factor induces cell migration and proliferation after glia-specific gene transfer in mice. Proc Natl Acad Sci USA 95: 1218-1223.[Abstract/Free Full Text]
  • Ichimura K., Schmidt EE, Goike HM, Collins VP (1996). Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene 13: 1065-1072.[Web of Science][Medline] [Order article via Infotrieve]
  • Kleihues P., Burger PC, Scheithauer BW (1993). Histological Typing Of Tumours of the Central Nervous System. Springer-Verlag, Berlin.
  • Kleihues P., Cavenee W. (1997). Pathology and Genetics of Tumors of the Nervous System. International Agency for Cancer Research, Lyon, France.
  • Kwan H., Pecenka V., Tsukamoto A., Parslow T., Guzman R., Lin T., Muller WJ, Lee FS, Leder P., Varmus HE (1992). Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Mol Cell Biol 12: 147-154.[Abstract/Free Full Text]
  • Lang FF, Miller DC, Koslow M., Newcomb EW (1994). Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 81: 427-436.[Web of Science][Medline] [Order article via Infotrieve]
  • Lothian C., Lendahl U. (1997). An evolutionarily conserved region in the second intron of the human nestin gene directs gene expression to CNS progenitor cells and to early neural crest cells. Eur J Neurosci 9: 452-462.[Medline] [Order article via Infotrieve]
  • Louis DN, von Deimling A., Chung RY, Rubio M., Waley JM, Eibl RH, Ohgaki H., Wiestler OD, Thor AD, Seizinger BR (1993). Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 52: 31-38.[Web of Science][Medline] [Order article via Infotrieve]
  • Nagane M., Coufal F., Lin H., Bogler O., Cavenee W., Huang H. (1996). A common mutant epidermal growth factor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and decreasing apoptosis. Cancer Res 56: 5079-5086.[Abstract/Free Full Text]
  • Ono Y., Yamiya T., Ichikawa T., Kunishio K., Matsumoto K., Furuta T., Ohmoto T., Ueki K., Louis DN (1996). Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J Neuropathol Exp Neurol 55: 1026-1031.[Web of Science][Medline] [Order article via Infotrieve]
  • Quelle DE, Zindy F., Ashmun RA, Sherr CJ (1995). Alternative reading frames of the INK4a tumor suppressor gene encoding two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rasheed BK, McLendon RE, Herndon JE, Friedman HS, Friedman AH, Bigner DD, Bigner SH (1994). Alterations of the TP53 gene in human gliomas. Cancer Res 54: 1324-1330.[Abstract/Free Full Text]
  • Schaefer-Klein J., Givol I., Barsov EV, Witcomb JM, VanBrocklin M., Foster DN, Federspiel MJ, Hughes SH (1998). The EV-O-derived cell line DF-1 supports the efficient replication of avian leukosis-sarcoma viruses and vectors. Virology 248: 305-311.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schlegel J., Merdes A., Stumm G., Albert FK, Forsting M., Hynes N., Kiessling M. (1994). Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behavior in human glioblastoma. Int J Cancer 56: 72-77.[Web of Science][Medline] [Order article via Infotrieve]
  • Serrano M., Hannon GJ, Beach D. (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707.[CrossRef][Medline] [Order article via Infotrieve]
  • Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho RA (1996). Role of the INK4a locus in tumor suppression and cell motility. Cell 85: 27-37.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • van Meyel DJ, Ransay DA, Casson AG, Keeney M., Chambers AF, Cairncross JG (1994). P53 mutation, expression and DNA ploidy in evolving gliomas: Evidence for two pathways of progression. J Natl Cancer Inst 86: 1011-1017.[Abstract/Free Full Text]
  • von Deimling A., von Ammon K., Schoenfeld D., Wiestler OD, Seizinger BR, Louis DN (1993). Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 3: 19-23.[Medline] [Order article via Infotrieve]
  • Watanabe K., Tachibana O., Sato K., Yonekawa Y., Kleihues P., Ohgaki H. (1996). Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6: 217-224.[Web of Science][Medline] [Order article via Infotrieve]
  • Wikstrand CJ, Hale LP, Batra SK, Hill ML, Humprhey PA, Kurpad SN, McLendon RE, Moscatello D., Pegram CN, Reist CJ, Traweek ST, Wong AJ, Zalutsky MR, Bigner DD (1995). Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinoma and malignant gliomas. Cancer Res 55: 3140-3148.[Abstract/Free Full Text]

Toxicologic Pathology, Vol. 28, No. 1, 171-177 (2000)
DOI: 10.1177/019262330002800122
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
J. N. Sarkaria, G. J. Kitange, C. D. James, R. Plummer, H. Calvert, M. Weller, and W. Wick
Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma
Clin. Cancer Res., May 15, 2008; 14(10): 2900 - 2908.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. P. Morton, M. E. Mongeau, D. S. Klimstra, J. P. Morris, Y. C. Lee, Y. Kawaguchi, C. V. E. Wright, M. Hebrok, and B. C. Lewis
Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis
PNAS, March 20, 2007; 104(12): 5103 - 5108.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Allen, S. Vongpunsawad, T. Nakamura, C. D. James, M. Schroeder, R. Cattaneo, C. Giannini, J. Krempski, K.-W. Peng, J. M. Goble, et al.
Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity against Gliomas with Increased Tumor Specificity
Cancer Res., December 15, 2006; 66(24): 11840 - 11850.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Gil-Perotin, M. Marin-Husstege, J. Li, M. Soriano-Navarro, F. Zindy, M. F. Roussel, J.-M. Garcia-Verdugo, and P. Casaccia-Bonnefil
Loss of p53 Induces Changes in the Behavior of Subventricular Zone Cells: Implication for the Genesis of Glial Tumors
J. Neurosci., January 25, 2006; 26(4): 1107 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. M. Carlson, J. L. Frandsen, N. Kirchhof, R. S. McIvor, and D. A. Largaespada
Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse
PNAS, November 22, 2005; 102(47): 17059 - 17064.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. D. Hemmati, I. Nakano, J. A. Lazareff, M. Masterman-Smith, D. H. Geschwind, M. Bronner-Fraser, and H. I. Kornblum
Cancerous stem cells can arise from pediatric brain tumors
PNAS, December 9, 2003; 100(25): 15178 - 15183.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Holland, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holland, E. C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?